Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001558370-22-002834
Filing Date
2022-03-04
Accepted
2022-03-03 18:24:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B2 tmb-20220303x424b2.htm 424B2 470269
2 GRAPHIC tmb-20220303x424b2001.jpg GRAPHIC 4530
3 GRAPHIC tmb-20220303x424b2004.jpg GRAPHIC 2569
4 GRAPHIC tmb-20220303x424b2003.jpg GRAPHIC 2574
  Complete submission text file 0001558370-22-002834.txt   485355
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B2 | Act: 33 | File No.: 333-259862 | Film No.: 22710966
SIC: 2834 Pharmaceutical Preparations